nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—Etoposide—uterine cancer	0.391	0.542	CbGbCtD
Nepafenac—PTGS1—Etoposide—uterine cancer	0.331	0.458	CbGbCtD
Nepafenac—Ocular discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0172	0.126	CcSEcCtD
Nepafenac—PTGS1—oviduct—uterine cancer	0.0172	0.147	CbGeAlD
Nepafenac—Mefenamic acid—AKR1C1—uterine cancer	0.0117	0.487	CrCbGaD
Nepafenac—PTGS1—artery—uterine cancer	0.0114	0.0972	CbGeAlD
Nepafenac—PTGS2—artery—uterine cancer	0.0109	0.0929	CbGeAlD
Nepafenac—Pregnancy—Progesterone—uterine cancer	0.00761	0.0558	CcSEcCtD
Nepafenac—Pregnancy—Medroxyprogesterone Acetate—uterine cancer	0.0069	0.0505	CcSEcCtD
Nepafenac—Mefenamic acid—AKR1C3—uterine cancer	0.00682	0.283	CrCbGaD
Nepafenac—PTGS2—myometrium—uterine cancer	0.00527	0.0449	CbGeAlD
Nepafenac—PTGS1—epithelium—uterine cancer	0.00433	0.0369	CbGeAlD
Nepafenac—Blood pressure increased—Progesterone—uterine cancer	0.00432	0.0316	CcSEcCtD
Nepafenac—PTGS1—uterine cervix—uterine cancer	0.00429	0.0365	CbGeAlD
Nepafenac—PTGS1—smooth muscle tissue—uterine cancer	0.00417	0.0355	CbGeAlD
Nepafenac—PTGS2—epithelium—uterine cancer	0.00414	0.0352	CbGeAlD
Nepafenac—PTGS2—uterine cervix—uterine cancer	0.0041	0.0349	CbGeAlD
Nepafenac—PTGS1—renal system—uterine cancer	0.00401	0.0342	CbGeAlD
Nepafenac—PTGS2—smooth muscle tissue—uterine cancer	0.00398	0.0339	CbGeAlD
Nepafenac—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.0287	CcSEcCtD
Nepafenac—PTGS1—endometrium—uterine cancer	0.00388	0.0331	CbGeAlD
Nepafenac—PTGS2—renal system—uterine cancer	0.00384	0.0327	CbGeAlD
Nepafenac—PTGS1—mammalian vulva—uterine cancer	0.00375	0.032	CbGeAlD
Nepafenac—PTGS2—endometrium—uterine cancer	0.00371	0.0316	CbGeAlD
Nepafenac—PTGS1—uterus—uterine cancer	0.00358	0.0305	CbGeAlD
Nepafenac—PTGS2—uterus—uterine cancer	0.00342	0.0291	CbGeAlD
Nepafenac—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.0239	CcSEcCtD
Nepafenac—Arthritis—Progesterone—uterine cancer	0.00323	0.0236	CcSEcCtD
Nepafenac—PTGS1—female reproductive system—uterine cancer	0.00321	0.0274	CbGeAlD
Nepafenac—PTGS2—female reproductive system—uterine cancer	0.00307	0.0262	CbGeAlD
Nepafenac—Diclofenac—CXCL8—uterine cancer	0.00294	0.122	CrCbGaD
Nepafenac—PTGS1—female gonad—uterine cancer	0.00292	0.0249	CbGeAlD
Nepafenac—PTGS1—vagina—uterine cancer	0.00291	0.0248	CbGeAlD
Nepafenac—PTGS2—female gonad—uterine cancer	0.0028	0.0238	CbGeAlD
Nepafenac—PTGS2—vagina—uterine cancer	0.00278	0.0237	CbGeAlD
Nepafenac—Ketoprofen—CXCL8—uterine cancer	0.00261	0.108	CrCbGaD
Nepafenac—Sinusitis—Progesterone—uterine cancer	0.00227	0.0166	CcSEcCtD
Nepafenac—Lacrimation—Epirubicin—uterine cancer	0.00211	0.0154	CcSEcCtD
Nepafenac—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.015	CcSEcCtD
Nepafenac—Eye disorder—Progesterone—uterine cancer	0.00203	0.0149	CcSEcCtD
Nepafenac—Angiopathy—Progesterone—uterine cancer	0.00197	0.0144	CcSEcCtD
Nepafenac—Immune system disorder—Progesterone—uterine cancer	0.00196	0.0144	CcSEcCtD
Nepafenac—Lacrimation—Doxorubicin—uterine cancer	0.00195	0.0143	CcSEcCtD
Nepafenac—Keratitis—Epirubicin—uterine cancer	0.00191	0.014	CcSEcCtD
Nepafenac—PTGS1—lymph node—uterine cancer	0.00188	0.016	CbGeAlD
Nepafenac—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.0135	CcSEcCtD
Nepafenac—PTGS2—lymph node—uterine cancer	0.0018	0.0153	CbGeAlD
Nepafenac—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.0131	CcSEcCtD
Nepafenac—Vision blurred—Progesterone—uterine cancer	0.00178	0.013	CcSEcCtD
Nepafenac—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.013	CcSEcCtD
Nepafenac—Keratitis—Doxorubicin—uterine cancer	0.00177	0.0129	CcSEcCtD
Nepafenac—Dermatitis atopic—Epirubicin—uterine cancer	0.00167	0.0123	CcSEcCtD
Nepafenac—Hypertension—Progesterone—uterine cancer	0.00163	0.0119	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.0016	0.0117	CcSEcCtD
Nepafenac—Dry mouth—Progesterone—uterine cancer	0.00157	0.0115	CcSEcCtD
Nepafenac—Dermatitis atopic—Doxorubicin—uterine cancer	0.00155	0.0113	CcSEcCtD
Nepafenac—Nervous system disorder—Progesterone—uterine cancer	0.00151	0.0111	CcSEcCtD
Nepafenac—Skin disorder—Progesterone—uterine cancer	0.0015	0.011	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.0106	CcSEcCtD
Nepafenac—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.0104	CcSEcCtD
Nepafenac—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.01	CcSEcCtD
Nepafenac—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00994	CcSEcCtD
Nepafenac—Lacrimation increased—Epirubicin—uterine cancer	0.00134	0.00985	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Progesterone—uterine cancer	0.00133	0.00975	CcSEcCtD
Nepafenac—Lacrimation increased—Doxorubicin—uterine cancer	0.00124	0.00911	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00883	CcSEcCtD
Nepafenac—Dry eye—Epirubicin—uterine cancer	0.00114	0.00838	CcSEcCtD
Nepafenac—Hypersensitivity—Progesterone—uterine cancer	0.00114	0.00832	CcSEcCtD
Nepafenac—Pruritus—Progesterone—uterine cancer	0.00109	0.00799	CcSEcCtD
Nepafenac—Dry eye—Doxorubicin—uterine cancer	0.00106	0.00775	CcSEcCtD
Nepafenac—Eye disorder—Etoposide—uterine cancer	0.00104	0.0076	CcSEcCtD
Nepafenac—Diabetes mellitus—Epirubicin—uterine cancer	0.00103	0.00757	CcSEcCtD
Nepafenac—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00754	CcSEcCtD
Nepafenac—Dizziness—Progesterone—uterine cancer	0.00102	0.00747	CcSEcCtD
Nepafenac—Angiopathy—Etoposide—uterine cancer	0.00101	0.00738	CcSEcCtD
Nepafenac—Immune system disorder—Etoposide—uterine cancer	0.001	0.00734	CcSEcCtD
Nepafenac—Eye pain—Epirubicin—uterine cancer	0.000996	0.0073	CcSEcCtD
Nepafenac—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000988	0.00724	CcSEcCtD
Nepafenac—Vomiting—Progesterone—uterine cancer	0.00098	0.00718	CcSEcCtD
Nepafenac—Headache—Progesterone—uterine cancer	0.000965	0.00707	CcSEcCtD
Nepafenac—Diabetes mellitus—Doxorubicin—uterine cancer	0.000956	0.00701	CcSEcCtD
Nepafenac—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000923	0.00677	CcSEcCtD
Nepafenac—Eye pain—Doxorubicin—uterine cancer	0.000921	0.00675	CcSEcCtD
Nepafenac—Nausea—Progesterone—uterine cancer	0.000915	0.00671	CcSEcCtD
Nepafenac—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000888	0.0065	CcSEcCtD
Nepafenac—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000875	0.00641	CcSEcCtD
Nepafenac—Hypertension—Etoposide—uterine cancer	0.000834	0.00611	CcSEcCtD
Nepafenac—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000829	0.00608	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000817	0.00598	CcSEcCtD
Nepafenac—Hypersensitivity—Dactinomycin—uterine cancer	0.000802	0.00588	CcSEcCtD
Nepafenac—Skin disorder—Etoposide—uterine cancer	0.000766	0.00561	CcSEcCtD
Nepafenac—Vomiting—Dactinomycin—uterine cancer	0.000693	0.00507	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Etoposide—uterine cancer	0.000681	0.00499	CcSEcCtD
Nepafenac—Sinusitis—Epirubicin—uterine cancer	0.00065	0.00476	CcSEcCtD
Nepafenac—Nausea—Dactinomycin—uterine cancer	0.000647	0.00474	CcSEcCtD
Nepafenac—Sinusitis—Doxorubicin—uterine cancer	0.000601	0.00441	CcSEcCtD
Nepafenac—Eye disorder—Epirubicin—uterine cancer	0.000581	0.00426	CcSEcCtD
Nepafenac—Hypersensitivity—Etoposide—uterine cancer	0.000581	0.00426	CcSEcCtD
Nepafenac—Angiopathy—Epirubicin—uterine cancer	0.000564	0.00413	CcSEcCtD
Nepafenac—Immune system disorder—Epirubicin—uterine cancer	0.000562	0.00412	CcSEcCtD
Nepafenac—Pruritus—Etoposide—uterine cancer	0.000558	0.00409	CcSEcCtD
Nepafenac—Eye disorder—Doxorubicin—uterine cancer	0.000538	0.00394	CcSEcCtD
Nepafenac—Angiopathy—Doxorubicin—uterine cancer	0.000522	0.00383	CcSEcCtD
Nepafenac—Dizziness—Etoposide—uterine cancer	0.000521	0.00382	CcSEcCtD
Nepafenac—Immune system disorder—Doxorubicin—uterine cancer	0.00052	0.00381	CcSEcCtD
Nepafenac—Vision blurred—Epirubicin—uterine cancer	0.00051	0.00374	CcSEcCtD
Nepafenac—Vomiting—Etoposide—uterine cancer	0.000501	0.00367	CcSEcCtD
Nepafenac—Headache—Etoposide—uterine cancer	0.000494	0.00362	CcSEcCtD
Nepafenac—Vision blurred—Doxorubicin—uterine cancer	0.000472	0.00346	CcSEcCtD
Nepafenac—Nausea—Etoposide—uterine cancer	0.000468	0.00343	CcSEcCtD
Nepafenac—Hypertension—Epirubicin—uterine cancer	0.000467	0.00342	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000458	0.00335	CcSEcCtD
Nepafenac—Dry mouth—Epirubicin—uterine cancer	0.000451	0.0033	CcSEcCtD
Nepafenac—Nervous system disorder—Epirubicin—uterine cancer	0.000433	0.00317	CcSEcCtD
Nepafenac—Hypertension—Doxorubicin—uterine cancer	0.000433	0.00317	CcSEcCtD
Nepafenac—Skin disorder—Epirubicin—uterine cancer	0.000429	0.00314	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000424	0.0031	CcSEcCtD
Nepafenac—Dry mouth—Doxorubicin—uterine cancer	0.000417	0.00306	CcSEcCtD
Nepafenac—Nervous system disorder—Doxorubicin—uterine cancer	0.000401	0.00294	CcSEcCtD
Nepafenac—Skin disorder—Doxorubicin—uterine cancer	0.000397	0.00291	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000382	0.00279	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000353	0.00259	CcSEcCtD
Nepafenac—Hypersensitivity—Epirubicin—uterine cancer	0.000326	0.00239	CcSEcCtD
Nepafenac—Pruritus—Epirubicin—uterine cancer	0.000313	0.00229	CcSEcCtD
Nepafenac—Hypersensitivity—Doxorubicin—uterine cancer	0.000301	0.00221	CcSEcCtD
Nepafenac—Dizziness—Epirubicin—uterine cancer	0.000292	0.00214	CcSEcCtD
Nepafenac—Pruritus—Doxorubicin—uterine cancer	0.000289	0.00212	CcSEcCtD
Nepafenac—Vomiting—Epirubicin—uterine cancer	0.000281	0.00206	CcSEcCtD
Nepafenac—Headache—Epirubicin—uterine cancer	0.000277	0.00203	CcSEcCtD
Nepafenac—Dizziness—Doxorubicin—uterine cancer	0.00027	0.00198	CcSEcCtD
Nepafenac—Nausea—Epirubicin—uterine cancer	0.000262	0.00192	CcSEcCtD
Nepafenac—Vomiting—Doxorubicin—uterine cancer	0.00026	0.0019	CcSEcCtD
Nepafenac—Headache—Doxorubicin—uterine cancer	0.000256	0.00188	CcSEcCtD
Nepafenac—Nausea—Doxorubicin—uterine cancer	0.000243	0.00178	CcSEcCtD
